Author

G. Turkoz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Harisankar· 1 shared B. C. Mandaci· 1 shared B. Dingiloglu· 1 shared C. Eren· 1 shared C. Pamukcu· 1 shared E. Celik· 1 shared E. Z. Ergun· 1 shared G. Dinler Doganay· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Harisankar

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintAug 9, 2022

Identification of GTF2IRD1 as a novel transcription factor essential for acute myeloid leukemia

Y. Heshmati, G. Turkoz, J. Zawacka…·J. Walfridsson

This study identifies GTF2IRD1 as a novel transcription factor essential for AML cell survival and disease progression, with potential therapeutic implications.

DOI 10.1101/2022.08.09.503300

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintDec 28, 2020

Lentiviral vector-based SARS-CoV-2 pseudovirus enables analysis of neutralizing activity in COVID-19 convalescent plasma

C. Pamukcu, E. Celik, E. Z. Ergun…·T. Sutlu

This study develops a lentiviral pseudovirus system to measure neutralizing activity in COVID-19 convalescent plasma, showing that neutralizing activity depends on antibody quality rather than quantity.

DOI 10.1101/2020.12.28.424590

humanexperimental assay

𝕏 PostBluesky